Suppr超能文献

澳大利亚国家脊髓灰质炎病毒参考实验室2008年年报。

Annual report of the Australian National Poliovirus Reference Laboratory, 2008.

作者信息

Roberts Jason A, Grant Kristina A, Yoon Yeon Kyung, Polychronopoulos Sophie, Ibrahim Aishah, Thorley Bruce R

机构信息

Victorian Infectious Diseases Reference Laboratory, North Melbourne, Victoria.

出版信息

Commun Dis Intell Q Rep. 2009 Sep;33(3):291-7.

Abstract

The Australian National Poliovirus Reference Laboratory (NPRL) is accredited by the World Health Organization (WHO) for the testing of stool specimens from cases of acute flaccid paralysis (AFP), a major clinical presentation of poliovirus infection. The NPRL, in collaboration with the Australian Paediatric Surveillance Unit, co-ordinates surveillance for cases of AFP in children in Australia, according to criteria recommended by the WHO. Clinical specimens are referred from AFP cases in children and suspected case of poliomyelitis in persons of any age. The WHO AFP surveillance performance indicator for a polio-free country such as Australia, is 1 non-polio AFP case per 100,000 children less than 15 years of age. In 2008, the Polio Expert Committee (PEC) classified 62 cases as non-polio AFP, or 1.51 non-polio AFP cases per 100,000 children aged less than 15 years. Poliovirus infection is confirmed by virus culture of stool specimens from AFP cases as other conditions that present with acute paralysis can mimic polio. While no poliovirus was reported in Australia from any source in 2008, the non-polio enteroviruses echovirus 25, coxsackievirus B2 and echovirus 11 were isolated from stool specimens of AFP cases. The last report of a wild poliovirus in Australia was due to an importation from Pakistan in 2007. With 4 countries remaining endemic for poliomyelitis--Afghanistan, India, Nigeria and Pakistan--and more than 1,600 confirmed cases of wild poliovirus infection in 18 countries in 2008, Australia continues to be at risk of further importation events.

摘要

澳大利亚国家脊髓灰质炎病毒参考实验室(NPRL)获得了世界卫生组织(WHO)的认可,负责检测急性弛缓性麻痹(AFP)病例的粪便标本,AFP是脊髓灰质炎病毒感染的主要临床表现。NPRL与澳大利亚儿科监测部门合作,根据WHO推荐的标准,对澳大利亚儿童的AFP病例进行监测。临床标本来自儿童AFP病例以及任何年龄人群的疑似脊髓灰质炎病例。对于像澳大利亚这样的无脊髓灰质炎国家,WHO的AFP监测绩效指标是每10万名15岁以下儿童中有1例非脊髓灰质炎AFP病例。2008年,脊髓灰质炎专家委员会(PEC)将62例病例归类为非脊髓灰质炎AFP,即每10万名15岁以下儿童中有1.51例非脊髓灰质炎AFP病例。由于其他伴有急性麻痹症状的疾病可能会与脊髓灰质炎相似,因此通过对AFP病例的粪便标本进行病毒培养来确诊脊髓灰质炎病毒感染。虽然2008年澳大利亚没有从任何来源报告脊髓灰质炎病毒,但从AFP病例的粪便标本中分离出了非脊髓灰质炎肠道病毒埃可病毒25型、柯萨奇病毒B2型和埃可病毒11型。澳大利亚上一次报告野生脊髓灰质炎病毒是在2007年,病毒从巴基斯坦输入。由于仍有4个国家存在脊髓灰质炎地方流行——阿富汗、印度、尼日利亚和巴基斯坦——且2008年在18个国家有超过1600例野生脊髓灰质炎病毒感染确诊病例,澳大利亚仍面临进一步输入病例的风险。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验